An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients with Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Ustekinumab
Related studies linked through entity extraction aliases.
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
- Status
- RECRUITING
- Phase
- PHASE4
A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ustekinumab Treatment in Children With Crohn's Disease
- Status
- COMPLETED
- Phase
- N/A
A Long-term Extension Study of Ustekinumab in Pediatric Participants
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Test Whether BI 706321 Combined With Ustekinumab Helps People With Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Symptom Improvement of Ulcerative Colitis After an Induction Dose of Ustekinumab in Japanese Clinical Practice
- Status
- COMPLETED
- Phase
- N/A
A Study of Ustekinumab in Participants With Takayasu Arteritis (TAK)
- Status
- TERMINATED
- Phase
- PHASE3
A Study to Assess the Bioequivalence of Ustekinumab by Two Different Injection Devices in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Compare SB17 (Proposed Ustekinumab Biosimilar) to European Union (EU) Sourced Stelara and United States of America (US) Sourced Stelara in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Status
- COMPLETED
- Phase
- PHASE3
A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease
- Status
- WITHDRAWN
- Phase
- PHASE2
Efficacy of Secukinumab Compared to Ustekinumab in Adults With Active Psoriatic Arthritis and Failure of TNFα-Inhibitor Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Induction Optimization With Stelara for Crohn's Disease
- Status
- TERMINATED
- Phase
- PHASE4
Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE3
Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2